Glutathione
GSH
Glutathione is your body's 'master antioxidant' — a molecule every cell makes to fight oxidative stress, power detoxification, and support the skin. It's used across wellness, longevity and dermatology, and it comes in several very different forms (oral, IV, injectable) with very different absorption. This guide covers how glutathione works, what the research shows, the routes and dosing, safety and status.
Glutathione quick facts
| Reported research dosing (Injectable) | 200mg-400mg |
| Route | Either |
| Cycle length | - |
| Frequency | 3 Days A Week |
| Half-life | ~10 min (IV); short |
| Forms | Injectable, Nasal |
| Evidence level | Human (supplement) |
| Other forms available | Nasal — dosed differently |
Detox and skin favorite. Injectable/IV gets around poor oral absorption.
How glutathione works
Glutathione (GSH) is a tripeptide and the cell's central antioxidant and detoxifier. It works two ways: directly neutralizing free radicals and pro-oxidants, and serving as the essential cofactor for antioxidant/detox enzymes (glutathione peroxidases and S-transferases). In the liver — where glutathione is 7–10× more concentrated than elsewhere — it drives Phase II detoxification, binding toxins into water-soluble forms the body can excrete. It's also the backbone of the cell's redox balance, which underlies immune function and healthy aging.
What the research shows — antioxidant, detox & skin
Antioxidant & detox: glutathione's role here is foundational and well established in cell biology — it's genuinely a master molecule for redox balance and liver detox.
Skin: this is its most popular consumer use. Research shows oral and topical glutathione can favorably affect pigmentation, brightness and hydration — it inhibits tyrosinase (the melanin-making enzyme), reducing excess pigment and fading hyperpigmentation, and supports tissue repair and elasticity. It's widely used as a skin-brightening agent, though the strength and durability of the skin-whitening effect is still debated in dermatology.
The routes matter — oral vs IV vs injection
This is the most important practical point about glutathione: how you take it changes everything.
Oral is convenient but poorly absorbed — hepatic metabolism breaks down 80–90% before it reaches circulation (roughly 10–20% bioavailability). Liposomal oral forms are designed to improve this. IV achieves near-complete (90–100%) bioavailability and can raise plasma glutathione ~47× above baseline — which is why clinics use it — but it requires medical supervision. Intramuscular injection is a middle ground used in community protocols.
Glutathione dosing (research reference)
Referenced ranges by route: oral ~250–1,000 mg/day (or ~100–500 mg/day liposomal, given better absorption); IV ~600–1,200 mg per infusion in clinical settings; IM ~200–600 mg a couple times weekly in community protocols. Injectable forms are reconstituted where applicable — the calculator above helps with the math. IV/injectable use should be medically supervised. This summarizes existing references for education only, not dosing advice.
Safety & side effects
Oral glutathione is generally very well tolerated. The cautions are with parenteral (IV/injection) use, which should be done under medical supervision: people with asthma have a documented risk of bronchospasm from IV glutathione (particularly above ~1,500 mg), and anyone with sulfite sensitivity should avoid glutathione injections entirely. As always, this is educational information, not medical advice.
Related compounds
Glutathione sits at the center of the antioxidant/longevity toolkit alongside NAC (N-acetylcysteine, a glutathione precursor) and NAD+. For skin specifically it's often paired with vitamin C, which supports its recycling.
Legal & regulatory status
Oral glutathione is widely sold as a supplement. Injectable/IV glutathione is used off-label in wellness and dermatology settings and is not FDA-approved as a skin-whitening or anti-aging therapy. Follow the laws and medical guidance that apply to you.
Where to get Glutathione
Glutathione is sold in 2 forms. They are not interchangeable — the dose and the route differ, so pick the one this page describes unless you know why you want another.
Glutathione reconstitution calculator
Research reconstitution calculator
Bacteriostatic water is the diluent — sterile water with 0.9% benzyl alcohol, which is what lets a vial be drawn from more than once. It does not come with the vial, and unlike the compound it is bought again every time.
Need bacteriostatic water? Get it at AminoWell USA (my company) → Code CAMERON.
The evidence for Glutathione
Graded by what exists behind each claim.
✅ Clinically validated
- Human trials support inhaled and intravenous glutathione in specific settings, and oral liposomal forms raise blood glutathione in small studies. There is no randomized trial supporting injected glutathione for general wellness or skin lightening.
- The IV skin-lightening use has caused documented harm — the Philippine FDA issued a formal warning after cases of kidney injury, Stevens-Johnson syndrome and death associated with high-dose IV use.
📊 Correlative data
- Widely used by injection, nasal spray and IV for antioxidant and skin goals. Reported experience is dominated by the sulfur taste and smell, which is near-universal and harmless.
🧪 Theoretical / extrapolated
- The body's principal endogenous antioxidant and a required cofactor for phase-2 liver detoxification. Depleted in oxidative stress and in paracetamol overdose, where NAC is given precisely to replenish it.
- The mechanistic argument against direct supplementation is strong: glutathione is synthesized inside cells from cysteine, and supplying the finished tripeptide bypasses a regulated pathway. That is why NAC — a precursor — has better evidence than glutathione itself.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Glutathione actually does
Glutathione is a tripeptide with one unusual bond, and that bond is the reason almost every supplement claim made about it is wrong in a specific, interesting way.
The bond. Glutathione is gamma-glutamyl-cysteinyl-glycine. The glutamate is joined to the cysteine through its side-chain carboxyl — a gamma linkage — not through the alpha-carboxyl that makes an ordinary peptide bond. Aminopeptidases cannot cleave a gamma bond. Exactly one enzyme in human physiology can: gamma-glutamyl transpeptidase, and it sits on the outer surface of cell membranes, facing outward.
Follow what that means for a swallowed capsule. Glutathione in the gut lumen or the bloodstream meets gamma-glutamyl transpeptidase on the enterocyte or the renal tubular cell. The enzyme removes the glutamate; a dipeptidase splits the remaining cysteinyl-glycine. The tripeptide is dismantled outside the cell, the amino acids are taken up separately, and the cell then resynthesizes glutathione inside itself. This is the gamma-glutamyl cycle, and it is not a side reaction — it is the normal route by which glutathione is handled. Oral or intravenous glutathione therefore mostly delivers cysteine, glutamate and glycine, not glutathione.
How the cell makes its own, and where the limit is. Two ATP-dependent steps: glutamate-cysteine ligase joins glutamate to cysteine, then glutathione synthetase adds glycine. The first step is rate-limiting and is feedback-inhibited by glutathione itself, which is the built-in ceiling on how much a cell will accumulate. Cysteine is the substrate in shortest supply, which is the entire pharmacological rationale for cysteine donors rather than for glutathione.
What it does once it is there, and it is three jobs not one. One: a thiol reductant, the substrate for glutathione peroxidase reducing hydrogen and lipid peroxides, regenerated from the oxidized dimer by glutathione reductase using NADPH — and the GSH:GSSG ratio, not the total, is the meaningful number. Two: the conjugating substrate for the glutathione S-transferases, the phase II enzymes that make electrophiles water-soluble; these are real enzymes with real chemistry, catalyzing defined reactions on defined substrates Steglich 2025 James 2017. Three: a copper and metal ligand, which is why glutathione participates directly in copper redox chemistry Ufnalska 2021.
And the mechanism behind the cosmetic use, which is a different enzyme entirely. Tyrosinase is the rate-limiting enzyme of melanogenesis and it is a copper enzyme. Thiols chelate that copper and also divert the pathway from eumelanin toward the lighter pheomelanin. The skin-lightening claim is copper chemistry at one enzyme, not antioxidant activity, and that distinction is set out in the review of thiol compounds Boo 2022.
Cell, rodent, human — and where it stops
Step one, biochemistry: settled, and it is the part that predicts the failures below. The gamma linkage, the gamma-glutamyl cycle and the feedback-inhibited synthesis step are textbook.
Step two, the human trial that most people quote wrongly. A randomized controlled clinical trial in 114 healthy older adults tested glycine and N-acetylcysteine supplementation on glutathione redox status and oxidative damage Lizzo 2022. It did not increase the whole-blood free GSH:GSSG ratio: placebo 12.49 against 12.65 in the 7.2 g arm at end of study, p = 0.739. That is a well-powered, randomized, negative result on the most sophisticated version of the strategy — supplying both limiting substrates rather than the tripeptide — and it is the single most important number on this page. Feedback inhibition of glutamate-cysteine ligase is exactly the mechanism that predicts it.
Step three, the cosmetic literature, which is where the human trials actually are. Glutathione as a skin-lightening agent and in melasma has been systematically reviewed Sarkar 2024, the metabolic basis and clinical evidence for thiol skin-lightening has its own review Boo 2022, and the oral-mucosal absorption route — sublingual or buccal, deliberately bypassing the gamma-glutamyl transpeptidase of the gut — has been reviewed against skin pigmentation endpoints Sharma 2022. Note what that third one concedes by existing: the route is being redesigned specifically because the ordinary one does not deliver the tripeptide.
Step four, the extrapolation, labeled as extrapolation. If the constraint is cysteine availability and the ceiling is feedback inhibition, then the interventions with a mechanistic case are cysteine donors, and the situations where they should work are those where glutathione is genuinely depleted rather than merely unmeasured. Acetaminophen overdose — where N-acetylcysteine is a licensed, life-saving antidote — is the proof that this logic is correct when the depletion is real. Extending it to a healthy person is the step the randomized trial above did not support Lizzo 2022.
Where the chain breaks. (1) The intravenous route bypasses the gut but not gamma-glutamyl transpeptidase, which is abundant in kidney and liver — consistent with the card's ~10 minute intravenous figure. (2) Blood glutathione is overwhelmingly intracellular in red cells and is a poor proxy for the tissue that matters. (3) The cosmetic literature uses pigmentation endpoints measured by instruments and by photographs, with the heterogeneity that implies Sarkar 2024. (4) Nobody has connected a measured rise in tissue glutathione to a clinical outcome in a healthy person.
What would have to be true, and how you would know it was not
Three predictions. The first tests whether anything happened at all, the second is the specific liver read-out, and the third is the one that cuts against the intravenous cosmetic use.
1. The right measurement is a ratio, and the honest prediction is a null. The meaningful number is the GSH:GSSG ratio, not total glutathione, because oxidation converts one to the other without changing the sum. In the randomized trial the ratio did not move on 7.2 g of glycine and N-acetylcysteine, p = 0.739 Lizzo 2022. The prediction of this page is that it will not move in a healthy person, and a person who measures it and finds no change has reproduced a published randomized result rather than done something wrong.
2. GGT is the marker that is actually about this pathway, and almost nobody uses it that way. GGT on a routine panel is read as a liver or alcohol marker. It is the enzyme of the gamma-glutamyl cycle: it is induced when the cell is working hard to salvage cysteine for glutathione synthesis, which is why a raised GGT is a marker of oxidative and xenobiotic load and not only of alcohol. Measure GGT at baseline and 12 weeks; a falling GGT alongside a reduced exposure is the most interpretable signal available on a standard panel.
3. The oxidative-damage endpoint, which is the one the trial used and the one that would falsify the whole premise. F2-isoprostane is a validated in vivo marker of lipid peroxidation and it is the right test rather than any total antioxidant capacity assay. Baseline and 12 weeks. If the GSH:GSSG ratio does not move and F2-isoprostane does not fall, nothing pharmacological has happened, and a CMP for liver enzymes and creatinine at the same points is what an intravenous product owes the person receiving it.
What nobody has tested yet
Four experiments nobody has run.
Nobody has measured tissue glutathione against blood glutathione in the same people on supplementation. Every negative blood result Lizzo 2022 is open to the objection that the tissue moved and the blood did not. Magnetic resonance spectroscopy can measure glutathione in brain and muscle non-invasively, and pairing it with the blood ratio in a randomized trial would close the argument in one study. It has not been done.
Nobody has stratified by glutathione S-transferase genotype. The GST enzymes are the conjugating step Steglich 2025 James 2017, and common whole-gene deletions of GSTM1 and GSTT1 mean a large fraction of any trial population lacks an entire isoform. Averaging deleted and non-deleted people together is a defensible way to miss an effect, and no supplementation trial has been analyzed that way.
Nobody has run a proper randomized trial of intravenous glutathione for skin lightening with objective colorimetry and adequate follow-up. The systematic reviews find a literature of small and heterogeneous studies Sarkar 2024 Boo 2022. Given the scale of the practice worldwide and the fact that it is an unlicensed injectable use, the absence of one good trial is remarkable.
Nobody has tested whether the buccal route actually delivers the intact tripeptide. The rationale for sublingual dosing is avoiding gut gamma-glutamyl transpeptidase Sharma 2022. The experiment is a pharmacokinetic study measuring intact glutathione against its constituent amino acids after buccal and oral dosing in the same people. Nobody has published it, which means the route's entire justification is untested.
Glutathione — its own safety story, not its class's
Oral glutathione is a widely sold supplement and its risk profile is unremarkable. The intravenous cosmetic use is a completely different proposition and it is the one this section is about.
Injectable glutathione for skin lightening is an unlicensed use of an injectable product, and that is the hazard. Regulators in several countries have issued warnings about injectable skin-lightening products, and the systematic review literature examines both the efficacy and the safety questions rather than treating the practice as established Sarkar 2024 Boo 2022. The risks are the ones that attach to any unlicensed injectable given outside a clinical setting: sterility, the actual content of the vial, the qualifications of whoever is administering it, and hypersensitivity reactions with no immediate means of treating them.
The oral product's realistic risk is that it does nothing. That is not a safety problem; it is a cost problem, and it is the most likely outcome given the gamma-glutamyl cycle and the randomized negative result Lizzo 2022.
N-acetylcysteine, the alternative this page keeps pointing at, has its own considerations. It is a licensed drug at therapeutic doses, it can cause gastrointestinal upset, and anaphylactoid reactions occur with intravenous administration. Recommending a cysteine donor over glutathione is a mechanistic argument, not a claim that the donor is free of consequences.
The copper interaction is worth knowing. Glutathione is a copper ligand and participates in copper redox chemistry Ufnalska 2021. In anybody with a disorder of copper handling — Wilson disease being the obvious one — that is not a neutral property.
What this page will not do. Recommend a dose, or endorse an injectable cosmetic use. The biochemistry says that supplying the tripeptide is the least efficient way to raise it, the best randomized trial of the better strategy was negative Lizzo 2022, and stating both plainly is more useful than another antioxidant claim.
Sources read for this page
- Lizzo G, et al. A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. Frontiers in Aging 2022 · PMID 35821844
- Sarkar R, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. International Journal of Dermatology 2024 · PMID 39444151
- Boo YC. Metabolic Basis and Clinical Evidence for Skin Lightening Effects of Thiol Compounds. Antioxidants (Basel) 2022 · PMID 35326153
- Sharma DK, et al. Augmented Glutathione Absorption from Oral Mucosa and its Effect on Skin Pigmentation: A Clinical Review. Clinical, Cosmetic and Investigational Dermatology 2022 · PMID 36117769
Glutathione — safety & side effects
- Well tolerated orally; a sulfur smell and GI upset are the usual reports.
- Oral glutathione is largely broken down before absorption — liposomal and S-acetyl forms do better, and NAC raises it more reliably than glutathione itself does. That is an efficacy limit, not a safety one.
- IV glutathione for skin lightening has caused serious harm including kidney injury, Stevens-Johnson syndrome and death, and the Philippine FDA and others have issued warnings. Oral use is not implicated.
- May cause bronchospasm in asthma (inhaled forms especially).
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Glutathione — safety, predicted from mechanism
Predicted from mechanism, not from a human safety trial. How that reasoning works →
What the mechanism predicts
Derived from the molecule, not a trial.
- These act on mitochondrial function, NAD+ availability, sirtuin signaling or cellular clearance. The honest prediction is that acute harm is unlikely and the interesting risks are theoretical and long-range — which is a different shape of risk, not an absence of one.
- Growth and clearance signals cut both ways. Anything that improves the efficiency of cell survival is also improving it for cells you would rather not keep. Anything that pushes clearance hard is doing so indiscriminately.
- The near-term, practical ones: NAD+ precursors and infusions commonly cause flushing and a strong sensation if pushed fast, and several compounds in this class are stimulating enough to disrupt sleep.
What has actually been reported
- Generally well tolerated at studied doses. NAD+ infusion discomfort is rate-dependent and resolves by slowing down.
- The human evidence is mostly short trials with surrogate endpoints — a marker moved, not a life changed. That is worth knowing before you build a decade-long habit on it.
How to reduce the risk
Same mechanism as the prediction.
- Slow the infusion rate. Almost all NAD+ discomfort is rate, not dose. There is no prize for finishing quickly.
- Dose earlier in the day. Several of these are subtly stimulating, and sleep is where most of the repair you are paying for happens.
- Pick an endpoint you can actually measure, and take the baseline before you start. This is the class most prone to spending years on something with no way of knowing whether it did anything.
- Fix the basics first. Sleep, training and bloodwork move the same markers further than anything on this list, and they are free. A longevity compound stacked on four hours of sleep is a rounding error.
What it does to your bloodwork
A fact about the assay.
- There is no NAD+ assay worth ordering clinically. Judge this class on downstream markers — inflammatory markers, lipids, fasting glucose, and whatever your baseline panel showed as out of range.
Don't run this if
- Active malignancy, for the survival-signaling reasoning above.
- Pregnancy — uncharacterized.
The honest unknown
- Whether any of it extends healthspan in humans. Every honest person in this field is running on mechanism and animal data, and this catalog should say so rather than imply otherwise.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
With food
Absorption is better with a meal, and for anything fat-soluble the fat is doing the work rather than the food generally. This is also the version that is easiest to actually remember, which matters more than it sounds.
From half-life and route, not a dosing trial.
Glutathione — interference & stacking
Predicted from mechanism, not from an interaction study. How mechanism-predicted claims are made →
What Glutathione moves on your bloodwork
Expected direction, not a measured one.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
This class is where honest expectation-setting matters most: the markers above are how you find out whether anything happened, and for most of these compounds that question is genuinely open.
Everything on this page, in an order
This one is free and stays free. What Skool adds is the rest of the shelf — 278 compounds and 371 supplements with the protocol, the stack order and the bloodwork to run beside it.
Join Skool — $10/mo →Bloodwork to run alongside Glutathione
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Comprehensive Metabolic Panel (CMP) | Liver function, where most glutathione claims are aimed |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Oxidative stress and inflammation, measured |
| F2-Isoprostane / Creatinine (Urine) | The closest thing to a direct oxidative-stress readout |
The Fatty Liver & Liver Health panel covers these in one order — 8 markers, $291.15 with the discount applied.
Check results you already have → · All 103 markers A–Z
Glutathione — frequently asked questions
What is glutathione?
Glutathione is a tripeptide your body makes in every cell — the 'master antioxidant.' It neutralizes free radicals, powers liver detoxification, and supports skin and healthy aging.
What does glutathione do for skin?
It inhibits tyrosinase (the melanin-making enzyme), which reduces excess pigment and can brighten skin and fade hyperpigmentation, and it supports repair and elasticity. It's widely used as a skin-brightening agent, though the effect's strength is still debated.
What's the difference between oral, IV, and injectable glutathione?
Oral is convenient but poorly absorbed (~10–20%; liposomal improves it). IV is near-complete (90–100%) bioavailability and can raise plasma levels ~47× — but needs medical supervision. IM injection is a middle ground.
How is glutathione dosed?
Referenced ranges: oral ~250–1,000 mg/day (or 100–500 mg liposomal); IV ~600–1,200 mg per infusion; IM ~200–600 mg a few times weekly. IV/injectable should be medically supervised. Educational, not dosing advice.
Is glutathione safe?
Oral glutathione is generally very well tolerated. IV/injectable use needs medical supervision — asthmatics have a bronchospasm risk (especially above ~1,500 mg IV) and people with sulfite sensitivity should avoid injections.
Is glutathione FDA-approved?
Oral glutathione is sold as a supplement. Injectable/IV glutathione is used off-label and is not FDA-approved as a skin-whitening or anti-aging therapy.
References & further reading
- Glutathione in skin aging & tissue regeneration — systematic review (MDPI)
- Systemic glutathione as a skin-whitening agent (PMC)
- Glutathione uses, benefits & dosage (Drugs.com)
Glutathione inside a finished plan
One arm of 3 Protocol Blueprints, free to read in full.
What Glutathione is used for
Glutathione appears under 4 goals in the goal router.
Related Longevity & Bioregulators compounds
Where this goes next
Glutathione is the photoprotection arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.